Federal funding for cancer research has remained flat for more than a decade, and when adjusted for inflation. ASCO is urging the federal government to take bold new action to ensure the pace of progress is not stalled.
Cancer Progress in Jeopardy: Stories From the Front Lines
What’s happening on the front lines in the laboratory and the clinic due to the shrinking federal funding for cancer research and clinical trials.
- “What Brilliant Minds Are We Losing?”—Here’s how a breast cancer research project at the Lombardi Comprehensive Cancer Center in Washington, DC, was affected by the 2013 budget sequestration.
- The Funding Crisis in Cancer Clinical Trials: A Focus on Cooperative Groups—Clinical trials supported by federal funding have led to important breakthroughs in cancer care. Federal spending cuts are taking a toll on cancer clinical trials.
|Click on the Federally Funded Research Badge above to learn more about using this graphic in your presentations.|
Share Your Story! ASCO wants to hear your story about how the budget cuts at NIH are affecting your research. Email email@example.com.
Federally Funded Cancer Research Educational Series
ASCO has developed an educational series of articles that explores the decade-long decline in federal funding for cancer research—and why this decline must be reversed.
- Federally Funded Cancer Research: The Catalyst for Progress Against Cancer
- Federally Funded Cancer Research: The Politics and Process of Medical Research Funding
- Federally Funded Cancer Research: The Key Role of the National Cancer Institute
Click to view ASCO Chief Medical Officer Richard L. Schilsky and former ASCO President and clinical trials pioneer James F. Holland discussing the importance of a federally-funded clinical trials network.
|Click to Expand|